DRUGS MADE IN AMERICA ACQUIS
DMII · NASDAQ
Updated at 2026-10-15 10:28:15
- Today's High
- $10.19
- Today’s Low
- $10.19
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $10.19
- Previous Close
- $10.19
- Volume
- 449
- Market Cap
- $649.1M
- P/E Ratio
- 49.85X
- EPS
- $0.80
Previous Day Range
52-Week Range
Company Overview
- Sector
- FINANCIAL SERVICES
- Industry
- N/A
- Sub-industry
- SHELL COMPANIES
- Headquarters
- 420 LEXINGTON AVENUE, NEW YORK, NY, UNITED STATES, 10170
- Country
- US
- Listing Date
- 2025-09-25
- Fiscal Year End
- December
- Shares Outstanding
- 63.7M
- CIK
- --
- Website
- --
Drugs Made In America Acquisition II Corp. (DMII) is a special purpose acquisition company (SPAC) focused on identifying and merging with innovative players in the pharmaceuticals and biotechnology sectors, prioritizing advancements in domestic drug manufacturing. Leveraging a seasoned management team with considerable industry expertise, DMII aims to execute strategic transactions that respond to market dynamics and foster sustainable practices. The company's mission encompasses enhancing supply chain resilience and promoting U.S. healthcare self-sufficiency, ultimately driving long-term value creation for shareholders and contributing to the growth of the American pharmaceutical landscape.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$112.22K
2026-03-31
$132.03K
2025-12-31
$1.04M
2025-09-30
$155.51K
Net Income
2026-06-30
$4.39M
2026-03-31
$4.33M
2025-12-31
$4.33M
2025-09-30
-$46.15K
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$0.06
2026-03-31
$0.06
2025-12-31
$0.06
2025-09-30
$0.00
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$112.22K
2026-03-31
-$132.03K
2025-12-31
-$1.04M
2025-09-30
-$46.15K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $112.22K | $132.03K | $1.04M | $155.51K |
| Net Income | $4.39M | $4.33M | $4.33M | -$46.15K |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $0.06 | $0.06 | $0.06 | $0.00 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$112.22K | -$132.03K | -$1.04M | -$46.15K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.